The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Horn Patrick Taylor since 2015.
This trader's CIK number is 1572002.
At the time of last reporting, Horn Patrick Taylor was the Chief Medical Officer of Albireo Pharma, Inc.. (stock ticker symbol ALBO).
Also see all insider trading activities at Albireo Pharma, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | TTPH | 0 | $0 | 0 | $0 | 10,000 | $20,299 |
| 2015 | TTPH | 0 | $0 | 30,000 | $1,353,400 | 30,000 | $60,897 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | ALBO | 0 | $0 | 385 | $12,474 | 0 | $0 |
| 2020 | ALBO | 0 | $0 | 715 | $17,803 | 0 | $0 |
1. Tetraphase Pharmaceuticals Inc (TTPH)
2. Albireo Pharma, Inc. (ALBO)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-06-13 | TTPH | Option Ex | 10,000 | 2.03 | 20,299 |
| 2015-08-13 | TTPH | Option Ex | 10,000 | 2.03 | 20,299 |
| 2015-08-13 | TTPH | Sale | 10,000 | 44.69 | 446,900 |
| 2015-07-13 | TTPH | Option Ex | 10,000 | 2.03 | 20,299 |
| 2015-07-13 | TTPH | Sale | 10,000 | 48.93 | 489,300 |
| 2015-06-12 | TTPH | Option Ex | 10,000 | 2.03 | 20,299 |
| 2015-06-12 | TTPH | Sale | 10,000 | 41.72 | 417,200 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-10-22 | ALBO | Sale | 95 | 28.83 | 2,738 |
| 2021-07-22 | ALBO | Sale | 90 | 34.13 | 3,071 |
| 2021-04-22 | ALBO | Sale | 90 | 31.75 | 2,857 |
| 2021-01-22 | ALBO | Sale | 110 | 34.62 | 3,808 |
| 2020-10-22 | ALBO | Sale | 89 | 34.55 | 3,074 |
| 2020-07-22 | ALBO | Sale | 91 | 25.80 | 2,347 |
| 2020-04-22 | ALBO | Sale | 92 | 17.64 | 1,622 |
| 2020-01-22 | ALBO | Sale | 443 | 24.29 | 10,760 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Horn Patrick Taylor (Chief Medical Officer of Albireo Pharma, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.